Dolors Soy

5.0k total citations
103 papers, 1.7k citations indexed

About

Dolors Soy is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Dolors Soy has authored 103 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 36 papers in Epidemiology and 26 papers in Infectious Diseases. Recurrent topics in Dolors Soy's work include Antibiotics Pharmacokinetics and Efficacy (35 papers), Antimicrobial Resistance in Staphylococcus (20 papers) and Pneumonia and Respiratory Infections (12 papers). Dolors Soy is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (35 papers), Antimicrobial Resistance in Staphylococcus (20 papers) and Pneumonia and Respiratory Infections (12 papers). Dolors Soy collaborates with scholars based in Spain, United States and Netherlands. Dolors Soy's co-authors include Joaquím Gascón, Elizabeth Posada, María‐Jesús Pinazo, Laura Guerrero, Francesc Marco, Asunción Moreno, Manel Almela, Yolanda Armero, Carlos A. Mestres and Ana del Rı́o and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and CHEST Journal.

In The Last Decade

Dolors Soy

98 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dolors Soy Spain 23 805 519 480 411 206 103 1.7k
Richard H. Drew United States 32 1.3k 1.6× 1.6k 3.1× 200 0.4× 521 1.3× 308 1.5× 86 2.7k
Kenneth J. Tack United States 24 622 0.8× 684 1.3× 294 0.6× 490 1.2× 358 1.7× 45 1.6k
Francisco Javier Candel Spain 22 677 0.8× 540 1.0× 194 0.4× 209 0.5× 282 1.4× 162 1.7k
Gerald R. Donowitz United States 23 1.2k 1.5× 1.1k 2.1× 207 0.4× 332 0.8× 232 1.1× 45 2.4k
Claude Carbón France 27 1.1k 1.4× 735 1.4× 269 0.6× 699 1.7× 290 1.4× 91 2.6k
Raymond Cha United States 20 242 0.3× 464 0.9× 146 0.3× 264 0.6× 227 1.1× 41 1.1k
Stefan Hagel Germany 22 753 0.9× 691 1.3× 193 0.4× 225 0.5× 294 1.4× 125 1.9k
R. F. Jacobs United States 22 1.2k 1.5× 1.1k 2.1× 190 0.4× 324 0.8× 69 0.3× 51 2.5k
Lavern M. Vercaigne Canada 20 625 0.8× 297 0.6× 104 0.2× 700 1.7× 100 0.5× 40 1.7k
George Foulds United States 25 940 1.2× 599 1.2× 222 0.5× 791 1.9× 54 0.3× 46 2.1k

Countries citing papers authored by Dolors Soy

Since Specialization
Citations

This map shows the geographic impact of Dolors Soy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolors Soy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolors Soy more than expected).

Fields of papers citing papers by Dolors Soy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dolors Soy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolors Soy. The network helps show where Dolors Soy may publish in the future.

Co-authorship network of co-authors of Dolors Soy

This figure shows the co-authorship network connecting the top 25 collaborators of Dolors Soy. A scholar is included among the top collaborators of Dolors Soy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dolors Soy. Dolors Soy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soy, Dolors, et al.. (2025). External validation of population pharmacokinetic models for meropenem in critically ill adult patients. Journal of Global Antimicrobial Resistance. 43. 358–364.
2.
Maroñas, Olalla, Ángel Carracedo, Irene Zarra‐Ferro, et al.. (2024). Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling. Psychiatry Research. 333. 115721–115721. 3 indexed citations
3.
Imaz, M.L., Mercè Torra, Klaus Langohr, et al.. (2024). Peripartum lithium management: Early maternal and neonatal outcomes. Journal of Affective Disorders. 366. 326–334. 1 indexed citations
4.
Echeverría-Esnal, Daniel, et al.. (2024). Clinically important pharmacokinetic drug-drug interactions with antibacterial agents. Revista Española de Quimioterapia. 37(4). 299–322. 4 indexed citations
5.
Vera, Paula, et al.. (2024). Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review. Antibiotics. 13(9). 801–801. 1 indexed citations
6.
Tuset, Montse, Cristina Pitart, Pedro Castro, et al.. (2023). Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series. Infectious Diseases and Therapy. 12(4). 1205–1216. 11 indexed citations
7.
Ulldemolins, Marta, Mireia Llauradó‐Serra, Chantal Csajka, et al.. (2021). Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration. European Journal of Clinical Pharmacology. 77(8). 1169–1180. 8 indexed citations
8.
Brasó‐Maristany, Fara, Miriam Sansó, Núria Chic, et al.. (2021). Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer. Frontiers in Oncology. 11. 710596–710596. 5 indexed citations
9.
Soy, Dolors, et al.. (2020). The safety of antimicrobials for the treatment of community-acquired pneumonia. Expert Opinion on Drug Safety. 19(5). 577–587. 1 indexed citations
10.
Soy, Dolors, et al.. (2020). Anticholinergic Burden and Safety Outcomes in Older Patients with Chronic Hepatitis C: A Retrospective Cohort Study. International Journal of Environmental Research and Public Health. 17(11). 3776–3776. 1 indexed citations
11.
Imaz, M.L., Mercè Torra, Dolors Soy, Lluïsa García-Esteve, & Rocı́o Martı́n-Santos. (2019). Clinical Lactation Studies of Lithium: A Systematic Review. Frontiers in Pharmacology. 10. 1005–1005. 18 indexed citations
12.
Rı́o, Ana del, C. García-de-la-Mària, José M. Entenza, et al.. (2015). Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 60(1). 478–486. 27 indexed citations
13.
Mària, Cristina García de la, Carlos Cervera, Juan M. Pericàs, et al.. (2015). Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration. PLoS ONE. 10(5). e0125818–e0125818. 20 indexed citations
14.
Pericàs, Juan M., Carlos Cervera, Ana del Rı́o, et al.. (2014). Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Clinical Microbiology and Infection. 20(12). O1075–O1083. 66 indexed citations
15.
Rey-Jurado, Emma, Griselda Tudó, Dolors Soy, & Julian González-Martín. (2013). Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model. International Journal of Antimicrobial Agents. 42(6). 524–530. 25 indexed citations
16.
Fernández‐Barat, Laia, Miquel Ferrer, Josep M. Sierra, et al.. (2012). Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes. Critical Care Medicine. 40(8). 2385–2389. 23 indexed citations
17.
Aldaz, Azucena, et al.. (2011). Monitorización farmacocinética de antiepilépticos. Farmacia Hospitalaria. 35(6). 326–339. 16 indexed citations
18.
Soy, Dolors, et al.. (2011). Linezolid Pharmacokinetics in Patients With Acute Renal Failure Undergoing Continuous Venovenous Hemodiafiltration. The Journal of Clinical Pharmacology. 52(9). 1430–1435. 15 indexed citations
19.
Colom, Helena, et al.. (2009). Population Pharmacokinetics of High-Dose Methotrexate After Intravenous Administration in Pediatric Patients With Osteosarcoma. Therapeutic Drug Monitoring. 31(1). 76–85. 32 indexed citations
20.
Soy, Dolors, et al.. (2002). Sirolimus: una nueva alternativa en el tratamiento inmunosupresor. Farmacia Hospitalaria. 26(2). 96–105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard H. Drew Breakdown of academic impact, for papers by Kenneth J. Tack Breakdown of academic impact, for papers by Francisco Javier Candel Breakdown of academic impact, for papers by Gerald R. Donowitz Breakdown of academic impact, for papers by Claude Carbón Breakdown of academic impact, for papers by Raymond Cha Breakdown of academic impact, for papers by Stefan Hagel Breakdown of academic impact, for papers by R. F. Jacobs Breakdown of academic impact, for papers by Lavern M. Vercaigne Breakdown of academic impact, for papers by George Foulds
Rankless by CCL
2026